Figure-01 (Figure 1)
This text appears to be showing data related to a research study or clinical trial comparing the efficiency of RSV (Respiratory Syncytial Virus) treatment versus a placebo. The data includes the number at risk and years of observation for the groups receiving RSV treatment and the placebo. Additionally, it mentions statistics such as the Hazard Ratio (HR), Confidence Interval (CI), significance level (P-value), and the sample sizes for each group. The study seems to have evaluated the efficacy of a treatment or intervention in potentially reducing the incidence or severity of a disease linked to RSV.*